User profiles for P. Fabbri

Paola Fabbri

Professore associato, Dip. Ingegneria Civile, Chimica, Ambiente e Materiali, Università di …
Verified email at unibo.it
Cited by 3935

[HTML][HTML] Additive manufacturing by digital light processing: a review

R Chaudhary, P Fabbri, E Leoni, F Mazzanti… - Progress in Additive …, 2023 - Springer
Additive manufacturing is a layer-by-layer strategy enabling the advanced design and
fabrication of complex 3D objects and structures, overcoming geometry limitations and reducing …

Guidelines for the diagnosis and treatment of dermatitis herpetiformis

M Caproni, E Antiga, L Melani, P Fabbri… - Journal of the …, 2009 - Wiley Online Library
Dermatitis herpetiformis is a rare disease that should be considered the cutaneous
expression of a gluten‐sensitive enteropathy indistinguishable from celiac disease. Dermatitis …

Wood chips size distribution in relation to blade wear and screen use

C Nati, R Spinelli, P Fabbri - Biomass and Bioenergy, 2010 - Elsevier
The study investigated the effect of wearing chipper knives on machine productivity, fuel
consumption and particles size distribution. The test included two different tree species (poplar …

New insights into the pathogenesis of vitiligo: imbalance of epidermal cytokines at sites of lesions

…, I Gallerani, M Fabiani, P Fabbri - Pigment Cell …, 2002 - Wiley Online Library
Vitiligo is a skin disease that is caused by selective destruction of melanocytes and is
characterized by white spots. Melanocytes and keratinocytes seem to exhibit a functional close …

Adjuvant chemotherapy in gastric cancer: a meta-analysis of randomized trials and a comparison with previous meta-analyses.

…, L Gianni, PP Fattori, D Tassinari, M Imola, P Fabbri… - Tumori, 2002 - europepmc.org
Up to now adjuvant chemotherapy after curative resection for gastric cancer (GC) has been
considered an experimental approach. The results of existing phase III randomized trials …

Localized scleroderma in adults and children. Clinical and laboratory investigations on 239 cases

…, S Menni, A Parodi, A Borghi, A Fuligni, P Fabbri… - European Journal of …, 2003 - jle.com
We examined, retrospectively, 239 patients (113 adults and 126 children) with LS, referred
to our department from 1980 up to 2001. Clinical parameters evaluated were age, sex, LS …

Serum levels of IL-17 and IL-22 are reduced by etanercept, but not by acitretin, in patients with psoriasis: a randomized-controlled trial

…, L Melani, W Volpi, E Del Bianco, P Fabbri - Journal of clinical …, 2009 - Springer
Introduction There are no controlled trials comparing etanercept and acitretin efficacy and
therapeutic mechanisms in psoriasis. Materials and methods In the present study, 30 patients …

The spectrum of cutaneous manifestations in lupus erythematosus—the Italian experience

…, M Caproni, E Bernacchi, L Amato, P Fabbri - Lupus, 2000 - journals.sagepub.com
We have evaluated the incidence of lupus erythematosus (LE)-specific skin disease in 186
patients with LE, seen retrospectively over a 1 0-year period at our Dermatology Department …

Modification of cellulose fibres with organosilanes: under what conditions does coupling occur?

M Castellano, A Gandini, P Fabbri… - Journal of colloid and …, 2004 - Elsevier
Different cellulose substrates and organosolv lignin were treated heterogeneously with
organic solutions of trialkoxysilanes bearing variable function on the forth substituent. It was …

Regulatory T cells in the skin lesions and blood of patients with systemic sclerosis and morphoea

…, A Marzano, MG Bernengo, P Fabbri… - British Journal of …, 2010 - academic.oup.com
Background Systemic sclerosis (SSc) and morphoea are connective tissue diseases
characterized by fibrosis of the skin. Although to date their pathogenesis has not been clearly …